Dose increases within the range determined by the prescribing physician may be considered for patients who are tolerating the medication well, based on provider assessment
CHAC1-mediated GSH degradation reduces S-glutathionylation of ARF6 at cysteine 90, thereby inactivating ARF6 and enhancing ferroptotic cell death (Ju et al., 2025)
We are also grateful for the contributions of the independent members of the trial oversight committees (Professors Michael Nicholson, Lorna Marson, Colin Wilson, Gabriel Oniscu, Nizam Mamode, Dr Nicholas Torpey, Dr Virginia Chiocchia, and Mr Steve Rogers), and for the support of the Oxford Transplant Centre (Oxford University Hospitals NHS Foundation Trust)
Advanced detox stackglutathione, B vitamins, PC, and milk thistle